Cargando…
A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients
The sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known. We describe four COVID-19 patients treated w...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354364/ https://www.ncbi.nlm.nih.gov/pubmed/32656711 http://dx.doi.org/10.1007/s10072-020-04591-3 |
_version_ | 1783558069383331840 |
---|---|
author | Sangalli, Davide Polonia, Valeria Colombo, Daniele Mantero, Vittorio Filizzolo, Marco Scaccabarozzi, Chiara Salmaggi, Andrea |
author_facet | Sangalli, Davide Polonia, Valeria Colombo, Daniele Mantero, Vittorio Filizzolo, Marco Scaccabarozzi, Chiara Salmaggi, Andrea |
author_sort | Sangalli, Davide |
collection | PubMed |
description | The sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known. We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke. Although rt-PA administration is the main therapeutic strategy, our patients experienced unpredictable complications and showed atypical features: the overall mortality was very high. In conclusion, in this article, we provide information about these cases and discuss the possible explanation behind this trend. |
format | Online Article Text |
id | pubmed-7354364 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73543642020-07-13 A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients Sangalli, Davide Polonia, Valeria Colombo, Daniele Mantero, Vittorio Filizzolo, Marco Scaccabarozzi, Chiara Salmaggi, Andrea Neurol Sci Covid-19 The sudden worldwide outbreak of Coronavirus Disease 2019 (COVID-19) has certainly provided new challenges in the management of acute ischaemic stroke, and the risk-benefit ratio of intravenous thrombolysis in COVID-19 positive patients is not well known. We describe four COVID-19 patients treated with intravenous thrombolysis for acute ischaemic stroke. Although rt-PA administration is the main therapeutic strategy, our patients experienced unpredictable complications and showed atypical features: the overall mortality was very high. In conclusion, in this article, we provide information about these cases and discuss the possible explanation behind this trend. Springer International Publishing 2020-07-12 2020 /pmc/articles/PMC7354364/ /pubmed/32656711 http://dx.doi.org/10.1007/s10072-020-04591-3 Text en © Fondazione Società Italiana di Neurologia 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Covid-19 Sangalli, Davide Polonia, Valeria Colombo, Daniele Mantero, Vittorio Filizzolo, Marco Scaccabarozzi, Chiara Salmaggi, Andrea A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title | A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title_full | A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title_fullStr | A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title_full_unstemmed | A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title_short | A single-centre experience of intravenous thrombolysis for stroke in COVID-19 patients |
title_sort | single-centre experience of intravenous thrombolysis for stroke in covid-19 patients |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354364/ https://www.ncbi.nlm.nih.gov/pubmed/32656711 http://dx.doi.org/10.1007/s10072-020-04591-3 |
work_keys_str_mv | AT sangallidavide asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT poloniavaleria asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT colombodaniele asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT manterovittorio asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT filizzolomarco asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT scaccabarozzichiara asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT salmaggiandrea asinglecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT sangallidavide singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT poloniavaleria singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT colombodaniele singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT manterovittorio singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT filizzolomarco singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT scaccabarozzichiara singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients AT salmaggiandrea singlecentreexperienceofintravenousthrombolysisforstrokeincovid19patients |